RUNX3 and acute myeloid leukemia: In terms of clinical attributes, high RUNX3 patients are significantly associated with poor cytogenetic risk AML subtypes, low white blood cell counts, and later diagnosis age compared to low RUNX3 patients (Supplementary Fig. S3).